Cargando…
Dual-release hydrocortisone treatment: glycometabolic profile and health-related quality of life
OBJECTIVE: Adrenal insufficiency (AI) is a chronic condition associated with increased mortality and morbidity. The treatment of AI in the last years has been object of important changes due to the development of a dual-release preparation of hydrocortisone. It differs from previous therapeutic stra...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793805/ https://www.ncbi.nlm.nih.gov/pubmed/29233815 http://dx.doi.org/10.1530/EC-17-0368 |